Bahrain vs Chad: HIV-positive TB patients on ART (antiretroviral therapy)
Bahrain
100.0%
in 2023
Chad
100.0%
in 2024
Bahrain rank
1st
Chad rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Bahrain
- Chad
How they compare
Bahrain currently reports 100.0% against 100.0% in Chad, a difference of 0.0%.
The two have swapped places 4 times across 9 shared years of data; in 2011 it was Chad ahead.
Bahrain ranks 1st and Chad ranks 1st of 144 countries.
Chad has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bahrain | Chad | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 66.0% | 68.8% | 2.8% | Chad |
| 2020s | 57.5% | 99.2% | 41.8% | Chad |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Bahrain or Chad?
- Bahrain, at 100.0% against 100.0% in Chad as of 2023.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Bahrain and Chad?
- 0.0%, with Bahrain ahead.
- How many years of comparable data are there for Bahrain and Chad?
- 9 years are reported by both, from 2011 to 2023.
- How do Bahrain and Chad rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Bahrain ranks 1st and Chad ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.